Tech Company Financing Transactions

Maze Therapeutics Funding Round

Arch Venture Partners, Third Rock Ventures and Alexandria Venture Investments participated in a $191 million funding round for Maze Therapeutics. The round was recorded on 3/1/2019.

Transaction Overview

Company Name
Announced On
3/1/2019
Transaction Type
Venture Equity
Amount
$191,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
131 Oyster Point Blvd. 200
San Francisco, CA 94080
USA
Phone
Undisclosed
Email Address
Overview
Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics. Advances in these areas have enabled us to decode the mysteries of genetic modifiers in a range of severe diseases, which we aim to turn into medicines that mimic protective mutations.
Profile
Maze Therapeutics LinkedIn Company Profile
Social Media
Maze Therapeutics Company Twitter Account
Company News
Maze Therapeutics News
Facebook
Maze Therapeutics on Facebook
YouTube
Maze Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Charles Homcy
  Charles Homcy LinkedIn Profile  Charles Homcy Twitter Account  Charles Homcy News  Charles Homcy on Facebook
President
Jason Coloma
  Jason Coloma LinkedIn Profile  Jason Coloma Twitter Account  Jason Coloma News  Jason Coloma on Facebook
Vice President
Timothy Behrens
  Timothy Behrens LinkedIn Profile  Timothy Behrens Twitter Account  Timothy Behrens News  Timothy Behrens on Facebook
Vice President
Matthew Brauer
  Matthew Brauer LinkedIn Profile  Matthew Brauer Twitter Account  Matthew Brauer News  Matthew Brauer on Facebook
Vice President
David Morgans
  David Morgans LinkedIn Profile  David Morgans Twitter Account  David Morgans News  David Morgans on Facebook
VP - Bus. Development
Tara Nickerson
  Tara Nickerson LinkedIn Profile  Tara Nickerson Twitter Account  Tara Nickerson News  Tara Nickerson on Facebook
VP - R & D
Eric Green
  Eric Green LinkedIn Profile  Eric Green Twitter Account  Eric Green News  Eric Green on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/1/2019: Beanfields venture capital transaction
Next: 3/1/2019: ThunderCore venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary